Oropharyngeal candidiasis in HIV(+) patients may influence the selection of HIV-1 protease variants

Virus Res. 2002 Aug;87(2):97-106. doi: 10.1016/s0168-1702(01)00428-2.

Abstract

Approximately 500 HIV-1 protease gene (pro) sequences were obtained from oral tissues (gingival cuff, buccal mucosa, tongue, palate) as well as saliva and peripheral blood mononuclear cells (PBMC) of 80 HIV-1 positive patients by nested amplification and manual sequencing of PCR products. By visual inspection each patient in this study exhibited a unique sequence profile. HIV-1 pro sequences obtained from patients with oropharyngeal candidiasis (OPC(+) patients) had significantly higher numbers of mutations than sequences from OPC(-) patients, but OPC(+) patients were no more likely to accumulate protease inhibitor resistance mutations than OPC(-) patients. Although the sequences for each patient were predominantly consistent between PBMC and oral tissues, approximately 10% of the patients demonstrated tissue specificity, and patients that demonstrated tissue specificity tended to be OPC(+). Furthermore, HIV-1 pro sequences derived from OPC lesions demonstrated unique mutations in approximately 30% of the patients who provided paired OPC(+/-) samples of the same tissue type. These data provide evidence for minimal compartmentalization of HIV-1 in oral tissues, yet some patients demonstrate minor variation between the HIV-1 pro sequences obtained from an OPC lesion and those obtained from a non-lesion site of similar tissue.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS-Related Opportunistic Infections / microbiology*
  • Amino Acid Sequence
  • Candidiasis, Oral / complications*
  • Candidiasis, Oral / virology
  • DNA, Viral / analysis
  • HIV Protease / genetics*
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / enzymology
  • HIV-1 / genetics*
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Polymerase Chain Reaction
  • Saliva
  • Sequence Analysis
  • Sequence Homology, Amino Acid

Substances

  • DNA, Viral
  • HIV Protease Inhibitors
  • HIV Protease